Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis.

Saved in:
Bibliographic Details
Title: Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis.
Authors: Hilton JBW; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia., Kysenius K; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia., Liddell JR; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia., Mercer SW; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia., Rautengarten C; School of Biosciences, The University of Melbourne, Victoria 3010, Australia., Hare DJ; Atomic Medicine Initiative, University of Technology Sydney, Australia., Buncic G; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia., Paul B; School of Geography, Earth and Atmospheric Sciences, The University of Melbourne, Victoria 3010, Australia; Elemental Scientific Lasers, LLC, 685 Old Buffalo Trail, Bozeman, MT 59715, United States., Murray SS; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia., McLean CA; Anatomical Pathology, The Alfred Hospital, Victoria 3004, Australia., Kilpatrick TJ; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia., Beckman JS; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, 97331, United States., Ayton S; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia; Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia., Bush AI; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia; Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3010, Australia., White AR; Queensland Institute of Medical Research Berghofer, Herston, Queensland 4006, Australia., Roberts BR; Department of Biochemistry, Emory University, Atlanta, GA 30322, United States., Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia., Crouch PJ; Department of Anatomy & Physiology, The University of Melbourne, Victoria 3010, Australia. Electronic address: pjcrouch@unimelb.edu.au.
Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Sep; Vol. 21 (5), pp. e00432. Date of Electronic Publication: 2024 Aug 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-7479
DOI:10.1016/j.neurot.2024.e00432